Fry Terry J相关文献与解析，生知库 | 链接生命科学的每一步

DeGolier, Kole R; Pham-Danis, Catherine; Burciaga, Samuel D; Walsh, Zachary H; Brzezinski, Christine; Novak, Amanda J; Leach, Lillie; Cimons, Jennifer; Li, Wei; Zhongyu, Zhu; Dimitrov, Dimiter; Scott-Browne, James P; Kohler, M Eric; Fry, Terry J

CD22

CD2

发表日期：2026

文献求助收藏

Ten-year experience of CD22 CAR T cells for children and young adults with B-cell acute lymphoblastic leukemia

CD22 CAR T 细胞治疗儿童和青少年 B 细胞急性淋巴细胞白血病的十年经验

期刊:Blood Advances

影响因子:7.1

doi:10.1182/bloodadvances.2025017753

Dreyzin, Alexandra; Yates, Bonnie; Shalabi, Haneen; Silbert, Sara K; Wang, Hao-Wei; Yuan, Constance M; Hoang, Chloe N; Culbert, August A; Gava, Flavia; Nair, Monica S; Giordani, Victoria M; Little, Lauren; Foley, Toni; Nussenblatt, Veronique; Fry, Terry J; Stroncek, David F; Highfill, Steven L; Shah, Nirali N

Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia

靶向胸腺基质淋巴细胞生成素受体可降低 CRLF2 重排 Ph 样和唐氏综合征急性淋巴细胞白血病的免疫治疗耐药性

期刊:Leukemia

影响因子:13.4

doi:10.1038/s41375-024-02493-3

Balestra, Tommaso; Niswander, Lisa M; Bagashev, Asen; Loftus, Joseph P; Ross, Savannah L; Chen, Robert K; McClellan, Samantha M; Junco, Jacob J; Bárcenas López, Diego A; Rabin, Karen R; Fry, Terry J; Tasian, Sarah K

The Paradox of Acute Myeloid Leukemia Responsiveness to Adoptive T-cell Therapy

急性髓系白血病对过继性T细胞疗法的反应悖论

期刊:Blood Cancer Discovery

影响因子:11.5

doi:10.1158/2643-3230.BCD-25-0017

T-bet overexpression enhances CAR T cell effector functions and antigen sensitivity

T-bet 过表达增强 CAR T 细胞效应功能和抗原敏感性

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2024-010962

Cimons, Jennifer M; DeGolier, Kole R; Burciaga, Samuel D; Yarnell, Michael C; Novak, Amanda J; Rivera-Reyes, Amalia M; Kohler, M Eric; Fry, Terry J

Increased NFAT activity with dual CAR stimulation in CD19xCD22 CAR T-cells is associated with decreased exhaustion and improved survival

CD19×CD22 CAR T细胞中双重CAR刺激引起的NFAT活性增强与耗竭减少和存活率提高相关。

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2025-011971

Rankin, Alexander W; Pham-Danis, Catherine; Novak, Amanda J; Danis, Etienne; Fry, Terry J; Kohler, M Eric

Characterization of a multiplex digital PCR assay to quantify total T cells relative to chimeric antigen receptor-positive T cells

对一种用于定量总T细胞相对于嵌合抗原受体阳性T细胞的多重数字PCR检测方法进行表征

期刊:Molecular Therapy Oncology

影响因子:5.3

doi:10.1016/j.omton.2025.200981

Murphy, Lindsey A; Sedivy, Laura; Kohler, M Eric; Jordan, Kimberly R; Ohm, Angela; Slansky, Jill E; Yarnell, Michael; Fry, Terry J; Winters, Amanda C

CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity

CD22 CAR T细胞相关的血液毒性、内皮细胞活化及其与神经毒性的关系

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2022-005898

Jess, Jennifer; Yates, Bonnie; Dulau-Florea, Alina; Parker, Kevin; Inglefield, Jon; Lichtenstein, Dan; Schischlik, Fiorella; Ongkeko, Martin; Wang, Yanyu; Shahani, Shilpa; Cullinane, Ann; Smith, Hannah; Kane, Eli; Little, Lauren; Chen, Dong; Fry, Terry J; Shalabi, Haneen; Wang, Hao-Wei; Satpathy, Ansuman; Lozier, Jay; Shah, Nirali N

Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against FLT3- mutant acute myeloid leukemia and KMT2A-rearranged acute lymphoblastic leukemia

FLT3靶向嵌合抗原受体T细胞免疫疗法对FLT3突变型急性髓系白血病和KMT2A重排型急性淋巴细胞白血病具有显著的临床前活性

期刊:Haematologica

影响因子:7.9

doi:10.3324/haematol.2022.281456

Niswander, Lisa M; Graff, Zachary T; Chien, Christopher D; Chukinas, John A; Meadows, Christina A; Leach, Lillie C; Loftus, Joseph P; Kohler, M Eric; Tasian, Sarah K; Fry, Terry J

Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure

嵌合抗原受体T细胞作为嵌合抗原受体T细胞治疗失败后的挽救疗法

期刊:Transplantation and Cellular Therapy

影响因子:4.4

doi:10.1016/j.jtct.2023.06.019

Holland, Elizabeth M; Yates, Bonnie; Steinberg, Seth M; Yuan, Constance M; Wang, Hao-Wei; Annesley, Colleen; Shalabi, Haneen; Stroncek, David; Fry, Terry J; Krueger, Joerg; Jacoby, Elad; Hsieh, Emily; Bhojwani, Deepa; Gardner, Rebecca A; Maude, Shannon L; Shah, Nirali N

Rational redesign of antigen binding domain improves in vivo efficacy of the CD22-CAR

对抗原结合域进行合理重新设计可提高CD22-CAR的体内疗效。

Ten-year experience of CD22 CAR T cells for children and young adults with B-cell acute lymphoblastic leukemia

CD22 CAR T 细胞治疗儿童和青少年 B 细胞急性淋巴细胞白血病的十年经验

Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia

靶向胸腺基质淋巴细胞生成素受体可降低 CRLF2 重排 Ph 样和唐氏综合征急性淋巴细胞白血病的免疫治疗耐药性

The Paradox of Acute Myeloid Leukemia Responsiveness to Adoptive T-cell Therapy

急性髓系白血病对过继性T细胞疗法的反应悖论

T-bet overexpression enhances CAR T cell effector functions and antigen sensitivity

T-bet 过表达增强 CAR T 细胞效应功能和抗原敏感性

Increased NFAT activity with dual CAR stimulation in CD19xCD22 CAR T-cells is associated with decreased exhaustion and improved survival

CD19×CD22 CAR T细胞中双重CAR刺激引起的NFAT活性增强与耗竭减少和存活率提高相关。

Characterization of a multiplex digital PCR assay to quantify total T cells relative to chimeric antigen receptor-positive T cells

对一种用于定量总T细胞相对于嵌合抗原受体阳性T细胞的多重数字PCR检测方法进行表征

CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity

CD22 CAR T细胞相关的血液毒性、内皮细胞活化及其与神经毒性的关系

Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against FLT3- mutant acute myeloid leukemia and KMT2A-rearranged acute lymphoblastic leukemia

FLT3靶向嵌合抗原受体T细胞免疫疗法对FLT3突变型急性髓系白血病和KMT2A重排型急性淋巴细胞白血病具有显著的临床前活性

Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure

嵌合抗原受体T细胞作为嵌合抗原受体T细胞治疗失败后的挽救疗法